Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panzyga in CIDP
NCT03166527Phase 3Unknown
- Start
- Jun 2017
- Primary completion
- Dec 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of intravenous immunoglobulin G in chronic inflammatory demyelinating polyneuropathy (CIDP). Status: unknown.
02
Drugs
intravenous immunoglobulin G
03
Conditions
chronic inflammatory demyelinating polyneuropathy (CIDP)
Beyond the preview
Go deeper on NCT03166527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03166527.